{"id":2272,"date":"2020-11-16T00:46:01","date_gmt":"2020-11-16T00:46:01","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=2272"},"modified":"2023-08-29T17:47:39","modified_gmt":"2023-08-29T17:47:39","slug":"alterity-therapeutics-collars-us-patent-next-generation-compounds","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=2272","title":{"rendered":"Alterity Therapeutics\u83b7\u5f97\u7f8e\u56fd\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u4e13\u5229"},"content":{"rendered":"<p><a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=ATH&amp;lang=cn\">Alterity Therapeutics (ASX: ATH)<\/a>\u83b7\u5f97\u4e86\u5176\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u7684\u7f8e\u56fd\u4e13\u5229\uff0c\u8be5\u5316\u5408\u7269\u65e8\u5728\u5e2e\u52a9\u6cbb\u7597\u5e15\u91d1\u68ee\u6c0f\u75c7\u548c\u963f\u5c14\u8328\u6d77\u9ed8\u6c0f\u75c7\u4ee5\u53ca\u5176\u4ed6\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u3002<\/p>\n<p>\u4eca\u5e743\u6708\uff0c\u8be5\u516c\u53f8\u5411\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40(US patent and Trademark Office)\u7533\u8bf7\u4e86\u8fd9\u9879\u4e13\u5229\uff0c\u7136\u540e\u63a5\u53d7\u4e86\u4f18\u5148\u5ba1\u67e5\u3002<\/p>\n<p>\u5b83\u662f\u57fa\u4e8eAlterity\u7684\u5185\u90e8\u53d1\u73b0\u7814\u7a76\uff0c\u662f\u5176\u4e0b\u4e00\u4ee3\u795e\u7ecf\u751f\u6210\u75be\u75c5\u836f\u7269\u5f00\u53d1\u7ec4\u5408\u7684\u6838\u5fc3\u3002<\/p>\n<p>\u201c\u6cbb\u7597\u75be\u75c5\u7684\u5316\u5408\u7269\u548c\u65b9\u6cd5\u201d\u4e13\u5229\u5305\u62ec150\u591a\u79cd\u65b0\u578b\u836f\u7269\u7ec4\u5408\u7269\uff0c\u53ef\u91cd\u65b0\u5206\u914d\u4e0e\u8fd9\u4e9b\u75be\u75c5\u6709\u5173\u7684\u4e0d\u7a33\u5b9a\u94c1\u3002<\/p>\n<p>Alterity\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98Geoffrey Kempler\u8868\u793a\uff0c\u8fd9\u9879\u5e7f\u6cdb\u7684\u4e13\u5229\u201c\u4e3a\u516c\u53f8\u5960\u5b9a\u4e86\u826f\u597d\u7684\u57fa\u7840\u201d\uff0c\u56e0\u4e3a\u8be5\u516c\u53f8\u6b63\u5728\u7814\u7a76\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u7684\u591a\u79cd\u6cbb\u7597\u65b9\u6cd5\u3002<\/p>\n<p>Kempler\u5148\u751f\u89e3\u91ca\u8bf4:\u201c\u5bf9\u4e8e\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u60a3\u8005\u5927\u8111\u4e2d\u94c1\u542b\u91cf\u5347\u9ad8\u7684\u5f71\u54cd\uff0c\u4e34\u5e8a\u548c\u79d1\u5b66\u4e0a\u7684\u5173\u6ce8\u6b63\u5728\u4e0d\u65ad\u589e\u52a0\u3002\u201d<\/p>\n<p>\u201cAlterity\u4e00\u76f4\u5904\u4e8e\u8be5\u9886\u57df\u7814\u7a76\u548c\u836f\u7269\u5f00\u53d1\u7684\u524d\u6cbf\uff0c\u6211\u4eec\u6709\u91cd\u8981\u7684\u7814\u7a76\u652f\u6301\u6211\u4eec\u5f53\u524d\u548c\u672a\u6765\u7684\u836f\u7269\u5f00\u53d1\u52aa\u529b\u3002\u201d<\/p>\n<p>Kempler\u5148\u751f\u8865\u5145\u8bf4\uff0c\u8fd9\u9879\u4e13\u5229\u5c06\u4fc3\u8fdbAlterity\u7684\u836f\u7269\u5f00\u53d1\u8ba1\u5212\uff0c\u4ee5\u89e3\u51b3\u4e00\u4e9b\u6700\u5177\u7834\u574f\u6027\u7684\u8111\u90e8\u75be\u75c5\uff0c\u8fd9\u4e9b\u75be\u75c5\u51e0\u4e4e\u6ca1\u6709\u6216\u6ca1\u6709\u6cbb\u7597\u9009\u62e9\u3002<\/p>\n<p>\u8be5\u4e13\u5229\u4e3aAlterity\u63d0\u4f9b\u4e8620\u5e74\u7684\u6280\u672f\u4e13\u6709\u6743\uff0c\u5e76\u652f\u6301\u8be5\u516c\u53f8\u7684\u4ea7\u54c1\u7ec4\u5408\uff0c\u5305\u62ec\u94c5\u5316\u5408\u7269ATH434\u3002<\/p>\n<h2>\u591a\u7cfb\u7edf\u840e\u7f29<\/h2>\n<p>Alterity\u516c\u53f8\u7684ATH434\u6cbb\u7597\u5e15\u91d1\u68ee\u75c5\u591a\u7cfb\u7edf\u840e\u7f29(MSA)\u6b63\u5728\u63a5\u53d7\u8bc4\u4f30\u3002<\/p>\n<p>MSA\u662f\u4e00\u79cd\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\uff0c\u5176\u8fd0\u52a8\u75c7\u72b6\u4e0e\u5e15\u91d1\u68ee\u6c0f\u75c5\u76f8\u4f3c\uff0c\u4f1a\u5bfc\u81f4\u81ea\u4e3b\u8fd0\u52a8\u534f\u8c03\u80fd\u529b\u7684\u4e27\u5931\u3002<\/p>\n<p>\u5b83\u8fd8\u635f\u5bb3\u7ef4\u6301\u6b63\u5e38\u8840\u538b\u3001\u6392\u4fbf\u529f\u80fd\u548c\u8180\u80f1\u63a7\u5236\u7684\u80fd\u529b\u3002<\/p>\n<p>MSA\u901a\u5e38\u572850\u5c81\u540e\u51fa\u73b0\u75c7\u72b6\u5e76\u8fc5\u901f\u53d1\u5c55\u3002\u968f\u7740\u75c5\u60c5\u7684\u8fdb\u5c55\uff0c\u60a3\u8005\u8fd8\u4f1a\u51fa\u73b0\u541e\u54bd\u56f0\u96be\u589e\u52a0\u3001\u58f0\u5e26\u9ebb\u75f9\u548c\u66f4\u5927\u7a0b\u5ea6\u7684\u4e0d\u6d3b\u52a8\u3002<\/p>\n<p>\u5b83\u6700\u7ec8\u5bfc\u81f4\u4e25\u91cd\u7684\u6b8b\u75be\u548c\u6b7b\u4ea1\u3002<\/p>\n<p>\u57281\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\uff0cAlterity\u5728\u6210\u4eba\u4e2d\u5b89\u5168\u6027\u3001\u8010\u53d7\u6027\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u65b9\u9762\u90fd\u53d6\u5f97\u4e86\u79ef\u6781\u8fdb\u5c55\uff0c\u8be5\u516c\u53f8\u5df2\u7ecf\u5f00\u59cb\u62db\u52dfMSA\u60a3\u8005\u53c2\u52a0\u751f\u7269\u5229\u7528\u8bd5\u9a8c\u3002<\/p>\n<p>\u8fd9\u9879\u7814\u7a76\u7684\u91cd\u8981\u4fe1\u606f\u5c06\u7528\u4e8e\u8ba1\u52122021\u5e74\u5e74\u4e2d\u8fdb\u884c\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86\u5176\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u7684\u7f8e\u56fd\u4e13\u5229\uff0c\u8be5\u5316\u5408\u7269\u65e8\u5728\u5e2e\u52a9\u6cbb\u7597\u5e15\u91d1\u68ee\u6c0f\u75c7\u548c\u963f\u5c14\u8328\u6d77\u9ed8\u6c0f\u75c7\u4ee5\u53ca\u5176\u4ed6\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u3002 \u4eca\u5e743\u6708\uff0c\u8be5\u516c\u53f8\u5411\u7f8e\u56fd\u4e13\u5229\u5546\u6807\u5c40(US patent and Trademark Office)\u7533\u8bf7\u4e86\u8fd9\u9879\u4e13\u5229\uff0c\u7136\u540e\u63a5\u53d7\u4e86\u4f18\u5148\u5ba1\u67e5\u3002 \u5b83\u662f\u57fa\u4e8eAlterity\u7684\u5185\u90e8\u53d1\u73b0\u7814\u7a76\uff0c\u662f\u5176\u4e0b\u4e00\u4ee3\u795e\u7ecf\u751f\u6210\u75be\u75c5\u836f\u7269\u5f00\u53d1\u7ec4\u5408\u7684\u6838\u5fc3\u3002 \u201c\u6cbb\u7597\u75be\u75c5\u7684\u5316\u5408\u7269\u548c\u65b9\u6cd5\u201d\u4e13\u5229\u5305\u62ec150\u591a\u79cd\u65b0\u578b\u836f\u7269\u7ec4\u5408\u7269\uff0c\u53ef\u91cd\u65b0\u5206\u914d\u4e0e\u8fd9\u4e9b\u75be\u75c5\u6709\u5173\u7684\u4e0d\u7a33\u5b9a\u94c1\u3002 Alterity\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98Geoffrey Kempler\u8868\u793a\uff0c\u8fd9\u9879\u5e7f\u6cdb\u7684\u4e13\u5229\u201c\u4e3a\u516c\u53f8\u5960\u5b9a\u4e86\u826f\u597d\u7684\u57fa\u7840\u201d\uff0c\u56e0\u4e3a\u8be5\u516c\u53f8\u6b63\u5728\u7814\u7a76\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u7684\u591a\u79cd\u6cbb\u7597\u65b9\u6cd5\u3002 Kempler\u5148\u751f\u89e3\u91ca\u8bf4:\u201c\u5bf9\u4e8e\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u60a3\u8005\u5927\u8111\u4e2d\u94c1\u542b\u91cf\u5347\u9ad8\u7684\u5f71\u54cd\uff0c\u4e34\u5e8a\u548c\u79d1\u5b66\u4e0a\u7684\u5173\u6ce8\u6b63\u5728\u4e0d\u65ad\u589e\u52a0\u3002\u201d \u201cAlterity\u4e00\u76f4\u5904\u4e8e\u8be5\u9886\u57df\u7814\u7a76\u548c\u836f\u7269\u5f00\u53d1\u7684\u524d\u6cbf\uff0c\u6211\u4eec\u6709\u91cd\u8981\u7684\u7814\u7a76\u652f\u6301\u6211\u4eec\u5f53\u524d\u548c\u672a\u6765\u7684\u836f\u7269\u5f00\u53d1\u52aa\u529b\u3002\u201d Kempler\u5148\u751f\u8865\u5145\u8bf4\uff0c\u8fd9\u9879\u4e13\u5229\u5c06\u4fc3\u8fdbAlterity\u7684\u836f\u7269\u5f00\u53d1\u8ba1\u5212\uff0c\u4ee5\u89e3\u51b3\u4e00\u4e9b\u6700\u5177\u7834\u574f\u6027\u7684\u8111\u90e8\u75be\u75c5\uff0c\u8fd9\u4e9b\u75be\u75c5\u51e0\u4e4e\u6ca1\u6709\u6216\u6ca1\u6709\u6cbb\u7597\u9009\u62e9\u3002 \u8be5\u4e13\u5229\u4e3aAlterity\u63d0\u4f9b\u4e8620\u5e74\u7684\u6280\u672f\u4e13\u6709\u6743\uff0c\u5e76\u652f\u6301\u8be5\u516c\u53f8\u7684\u4ea7\u54c1\u7ec4\u5408\uff0c\u5305\u62ec\u94c5\u5316\u5408\u7269ATH434\u3002 \u591a\u7cfb\u7edf\u840e\u7f29 Alterity\u516c\u53f8\u7684ATH434\u6cbb\u7597\u5e15\u91d1\u68ee\u75c5\u591a\u7cfb\u7edf\u840e\u7f29(MSA)\u6b63\u5728\u63a5\u53d7\u8bc4\u4f30\u3002 MSA\u662f\u4e00\u79cd\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\uff0c\u5176\u8fd0\u52a8\u75c7\u72b6\u4e0e\u5e15\u91d1\u68ee\u6c0f\u75c5\u76f8\u4f3c\uff0c\u4f1a\u5bfc\u81f4\u81ea\u4e3b\u8fd0\u52a8\u534f\u8c03\u80fd\u529b\u7684\u4e27\u5931\u3002 \u5b83\u8fd8\u635f\u5bb3\u7ef4\u6301\u6b63\u5e38\u8840\u538b\u3001\u6392\u4fbf\u529f\u80fd\u548c\u8180\u80f1\u63a7\u5236\u7684\u80fd\u529b\u3002 MSA\u901a\u5e38\u572850\u5c81\u540e\u51fa\u73b0\u75c7\u72b6\u5e76\u8fc5\u901f\u53d1\u5c55\u3002\u968f\u7740\u75c5\u60c5\u7684\u8fdb\u5c55\uff0c\u60a3\u8005\u8fd8\u4f1a\u51fa\u73b0\u541e\u54bd\u56f0\u96be\u589e\u52a0\u3001\u58f0\u5e26\u9ebb\u75f9\u548c\u66f4\u5927\u7a0b\u5ea6\u7684\u4e0d\u6d3b\u52a8\u3002 \u5b83\u6700\u7ec8\u5bfc\u81f4\u4e25\u91cd\u7684\u6b8b\u75be\u548c\u6b7b\u4ea1\u3002 \u57281\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\uff0cAlterity\u5728\u6210\u4eba\u4e2d\u5b89\u5168\u6027\u3001\u8010\u53d7\u6027\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u65b9\u9762\u90fd\u53d6\u5f97\u4e86\u79ef\u6781\u8fdb\u5c55\uff0c\u8be5\u516c\u53f8\u5df2\u7ecf\u5f00\u59cb\u62db\u52dfMSA\u60a3\u8005\u53c2\u52a0\u751f\u7269\u5229\u7528\u8bd5\u9a8c\u3002 \u8fd9\u9879\u7814\u7a76\u7684\u91cd\u8981\u4fe1\u606f\u5c06\u7528\u4e8e\u8ba1\u52122021\u5e74\u5e74\u4e2d\u8fdb\u884c\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n","protected":false},"author":3,"featured_media":10039,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[403],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Alterity Therapeutics\u83b7\u5f97\u7f8e\u56fd\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u4e13\u5229<\/title>\n<meta name=\"description\" content=\"Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86\u5176\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u7684\u7f8e\u56fd\u4e13\u5229\uff0c\u8be5\u5316\u5408\u7269\u65e8\u5728\u5e2e\u52a9\u6cbb\u7597\u5e15\u91d1\u68ee\u6c0f\u75c7\u548c\u963f\u5c14\u8328\u6d77\u9ed8\u6c0f\u75c7\u4ee5\u53ca\u5176\u4ed6\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alterity Therapeutics\u83b7\u5f97\u7f8e\u56fd\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u4e13\u5229\" \/>\n<meta property=\"og:description\" content=\"Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86\u5176\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u7684\u7f8e\u56fd\u4e13\u5229\uff0c\u8be5\u5316\u5408\u7269\u65e8\u5728\u5e2e\u52a9\u6cbb\u7597\u5e15\u91d1\u68ee\u6c0f\u75c7\u548c\u963f\u5c14\u8328\u6d77\u9ed8\u6c0f\u75c7\u4ee5\u53ca\u5176\u4ed6\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-collars-us-patent-next-generation-compounds\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-16T00:46:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:47:39+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/11\/Alterity-Therapeutics-ASX-ATH-neurodegenerative-diseases-drug.jpg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Alterity Therapeutics\u83b7\u5f97\u7f8e\u56fd\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u4e13\u5229\" \/>\n<meta name=\"twitter:description\" content=\"Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86\u5176\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u7684\u7f8e\u56fd\u4e13\u5229\uff0c\u8be5\u5316\u5408\u7269\u65e8\u5728\u5e2e\u52a9\u6cbb\u7597\u5e15\u91d1\u68ee\u6c0f\u75c7\u548c\u963f\u5c14\u8328\u6d77\u9ed8\u6c0f\u75c7\u4ee5\u53ca\u5176\u4ed6\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/11\/Alterity-Therapeutics-ASX-ATH-neurodegenerative-diseases-drug.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-collars-us-patent-next-generation-compounds\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-collars-us-patent-next-generation-compounds\/\",\"name\":\"Alterity Therapeutics\u83b7\u5f97\u7f8e\u56fd\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u4e13\u5229\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-11-16T00:46:01+00:00\",\"dateModified\":\"2023-08-29T17:47:39+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86\u5176\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u7684\u7f8e\u56fd\u4e13\u5229\uff0c\u8be5\u5316\u5408\u7269\u65e8\u5728\u5e2e\u52a9\u6cbb\u7597\u5e15\u91d1\u68ee\u6c0f\u75c7\u548c\u963f\u5c14\u8328\u6d77\u9ed8\u6c0f\u75c7\u4ee5\u53ca\u5176\u4ed6\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-collars-us-patent-next-generation-compounds\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-collars-us-patent-next-generation-compounds\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-collars-us-patent-next-generation-compounds\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alterity Therapeutics\u83b7\u5f97\u7f8e\u56fd\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u4e13\u5229\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Alterity Therapeutics\u83b7\u5f97\u7f8e\u56fd\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u4e13\u5229","description":"Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86\u5176\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u7684\u7f8e\u56fd\u4e13\u5229\uff0c\u8be5\u5316\u5408\u7269\u65e8\u5728\u5e2e\u52a9\u6cbb\u7597\u5e15\u91d1\u68ee\u6c0f\u75c7\u548c\u963f\u5c14\u8328\u6d77\u9ed8\u6c0f\u75c7\u4ee5\u53ca\u5176\u4ed6\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Alterity Therapeutics\u83b7\u5f97\u7f8e\u56fd\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u4e13\u5229","og_description":"Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86\u5176\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u7684\u7f8e\u56fd\u4e13\u5229\uff0c\u8be5\u5316\u5408\u7269\u65e8\u5728\u5e2e\u52a9\u6cbb\u7597\u5e15\u91d1\u68ee\u6c0f\u75c7\u548c\u963f\u5c14\u8328\u6d77\u9ed8\u6c0f\u75c7\u4ee5\u53ca\u5176\u4ed6\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-collars-us-patent-next-generation-compounds\/","og_site_name":"smallcapsCN","article_published_time":"2020-11-16T00:46:01+00:00","article_modified_time":"2023-08-29T17:47:39+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/11\/Alterity-Therapeutics-ASX-ATH-neurodegenerative-diseases-drug.jpg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_title":"Alterity Therapeutics\u83b7\u5f97\u7f8e\u56fd\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u4e13\u5229","twitter_description":"Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86\u5176\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u7684\u7f8e\u56fd\u4e13\u5229\uff0c\u8be5\u5316\u5408\u7269\u65e8\u5728\u5e2e\u52a9\u6cbb\u7597\u5e15\u91d1\u68ee\u6c0f\u75c7\u548c\u963f\u5c14\u8328\u6d77\u9ed8\u6c0f\u75c7\u4ee5\u53ca\u5176\u4ed6\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/11\/Alterity-Therapeutics-ASX-ATH-neurodegenerative-diseases-drug.jpg","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-collars-us-patent-next-generation-compounds\/","url":"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-collars-us-patent-next-generation-compounds\/","name":"Alterity Therapeutics\u83b7\u5f97\u7f8e\u56fd\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u4e13\u5229","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-11-16T00:46:01+00:00","dateModified":"2023-08-29T17:47:39+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"Alterity Therapeutics (ASX: ATH)\u83b7\u5f97\u4e86\u5176\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u7684\u7f8e\u56fd\u4e13\u5229\uff0c\u8be5\u5316\u5408\u7269\u65e8\u5728\u5e2e\u52a9\u6cbb\u7597\u5e15\u91d1\u68ee\u6c0f\u75c7\u548c\u963f\u5c14\u8328\u6d77\u9ed8\u6c0f\u75c7\u4ee5\u53ca\u5176\u4ed6\u795e\u7ecf\u9000\u884c\u6027\u75be\u75c5\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-collars-us-patent-next-generation-compounds\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-collars-us-patent-next-generation-compounds\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/alterity-therapeutics-collars-us-patent-next-generation-compounds\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Alterity Therapeutics\u83b7\u5f97\u7f8e\u56fd\u4e0b\u4e00\u4ee3\u5316\u5408\u7269\u4e13\u5229"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2272"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2272"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2272\/revisions"}],"predecessor-version":[{"id":10038,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2272\/revisions\/10038"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/10039"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2272"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2272"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}